| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study
|
Koga, Takamasa
|
|
2018
|
126 |
C |
p. 72-79
|
artikel
|
| 2 |
Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysis
|
Petrelli, Fausto
|
|
2018
|
126 |
C |
p. 194-200
|
artikel
|
| 3 |
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations
|
Imai, Hisao
|
|
2018
|
126 |
C |
p. 41-47
|
artikel
|
| 4 |
Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma
|
Tranchant, Robin
|
|
2018
|
126 |
C |
p. 15-24
|
artikel
|
| 5 |
Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients
|
Anai, Satoshi
|
|
2018
|
126 |
C |
p. 156-161
|
artikel
|
| 6 |
Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks – Initial results
|
Schwyzer, Moritz
|
|
2018
|
126 |
C |
p. 170-173
|
artikel
|
| 7 |
Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia
|
Ueda, Takuya
|
|
2018
|
126 |
C |
p. 162-169
|
artikel
|
| 8 |
Clinical, pathological and treatment factors associated with the survival of patients with primary pulmonary salivary gland-type tumors
|
Qin, Bao-Dong
|
|
2018
|
126 |
C |
p. 174-181
|
artikel
|
| 9 |
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies
|
Wu, Yi-Long
|
|
2018
|
126 |
C |
p. 1-8
|
artikel
|
| 10 |
Comment on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
|
Xu, Ran
|
|
2018
|
126 |
C |
p. 224
|
artikel
|
| 11 |
Contents
|
|
|
2018
|
126 |
C |
p. v-vii
|
artikel
|
| 12 |
Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas
|
Hu, Szu-Yen
|
|
2018
|
126 |
C |
p. 189-193
|
artikel
|
| 13 |
Corrigendum to “Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab” [Lung Cancer 115 (2018) 71–74]
|
Sato, Koichi
|
|
2018
|
126 |
C |
p. 230-231
|
artikel
|
| 14 |
Detection of oligoprogressive disease in oncogene-addicted non-small cell lung cancer using PET/CT versus CT in patients receiving a tyrosine kinase inhibitor
|
Ng, Terry L.
|
|
2018
|
126 |
C |
p. 112-118
|
artikel
|
| 15 |
Early initiated postoperative rehabilitation reduces fatigue in patients with operable lung cancer: A randomized trial
|
Quist, Morten
|
|
2018
|
126 |
C |
p. 125-132
|
artikel
|
| 16 |
Editorial Board
|
|
|
2018
|
126 |
C |
p. iii
|
artikel
|
| 17 |
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data
|
Dudnik, Elizabeth
|
|
2018
|
126 |
C |
p. 217-223
|
artikel
|
| 18 |
Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro
|
Nishino, Masaya
|
|
2018
|
126 |
C |
p. 149-155
|
artikel
|
| 19 |
EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer
|
John, Thomas
|
|
2018
|
126 |
C |
p. 133-138
|
artikel
|
| 20 |
Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis
|
Udagawa, Hibiki
|
|
2018
|
126 |
C |
p. 182-188
|
artikel
|
| 21 |
Genomic changes of chromosomes 8p23.1 and 1q21: Novel mutations in malignant mesothelioma
|
Serio, Gabriella
|
|
2018
|
126 |
C |
p. 106-111
|
artikel
|
| 22 |
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer
|
Hashemi Sadraei, Nooshin
|
|
2018
|
126 |
C |
p. 48-54
|
artikel
|
| 23 |
Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma
|
Sakai, Takashi
|
|
2018
|
126 |
C |
p. 64-71
|
artikel
|
| 24 |
Molecular determinants of acquired resistance to BRAF inhibition in human lung cancer
|
Lucchesi, Carlo
|
|
2018
|
126 |
C |
p. 227-229
|
artikel
|
| 25 |
New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study
|
Klikovits, Thomas
|
|
2018
|
126 |
C |
p. 139-148
|
artikel
|
| 26 |
Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer
|
Morel, Hugues
|
|
2018
|
126 |
C |
p. 55-63
|
artikel
|
| 27 |
Radiotherapy dose escalation in locally advanced NSCLC – The limits of conventional radiochemotherapy
|
Guckenberger, Matthias
|
|
2018
|
126 |
C |
p. 208-209
|
artikel
|
| 28 |
Real life experience with nivolumab for the treatment of non-small cell lung carcinoma
|
Schouten, Robert D.
|
|
2018
|
126 |
C |
p. 210-216
|
artikel
|
| 29 |
Reply to the comments on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
|
Zhao, Binghao
|
|
2018
|
126 |
C |
p. 225-226
|
artikel
|
| 30 |
Statins associate with improved mortality among patients with certain histological subtypes of lung cancer
|
Ung, Matthew H.
|
|
2018
|
126 |
C |
p. 89-96
|
artikel
|
| 31 |
Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcome
|
Menoux, I.
|
|
2018
|
126 |
C |
p. 201-207
|
artikel
|
| 32 |
Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations
|
Kazdal, Daniel
|
|
2018
|
126 |
C |
p. 80-88
|
artikel
|
| 33 |
Systemic treatments for thymoma and thymic carcinoma: A systematic review
|
Berghmans, Thierry
|
|
2018
|
126 |
C |
p. 25-31
|
artikel
|
| 34 |
Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer
|
Meijer, Tineke W.H.
|
|
2018
|
126 |
C |
p. 32-40
|
artikel
|
| 35 |
The cost-effectiveness of the Manchester ‘lung health checks’, a community-based lung cancer low-dose CT screening pilot
|
Hinde, Sebastian
|
|
2018
|
126 |
C |
p. 119-124
|
artikel
|
| 36 |
Ultrasonographic characteristics of lymph nodes as predictors of malignancy during endobronchial ultrasound (EBUS): A systematic review
|
Hylton, Danielle A.
|
|
2018
|
126 |
C |
p. 97-105
|
artikel
|
| 37 |
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer
|
Capizzi, Elisa
|
|
2018
|
126 |
C |
p. 9-14
|
artikel
|
Tijdschrift beschrijving